arrow
K

Katrina M. Pollock

imperial college london
H指数:29
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadth

使用稳定类天然HIV-1 Env免疫原的实验医学研究能够驱动长期抗体应答,但缺乏广谱中和能力。

2025-02-010
OAAI
An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, doubleblind trial
2024-08-016
OAAI
Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or Tofacitinib

使用英夫利昔单抗或托法替尼的炎症性肠病患者对流感疫苗的抗体反应减弱

2023-11-062
OAAI
Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study

炎症性肠病患者在三剂新型冠状病毒肺炎疫苗 (VIP) 后中和针对SARS-CoV-2 Omicron BA.4/5和野生型病毒的抗体反应: 一项前瞻性、多中心、队列研究

2023-10-013
OAAI
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19 A Randomized Clinical Trial

血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂对新型冠状病毒肺炎住院患者无器官支持天数的影响随机临床试验

2023-04-1135
OA
Characterization of Rare Spontaneous Human Immunodeficiency Virus Viral Controllers Attending a National United Kingdom Clinical Service Using a Combination of Serology and Molecular Diagnostic Assays

使用血清学和分子诊断分析相结合的方法,对参加英国国家临床服务的罕见自发性人类免疫缺陷病病毒病毒控制者进行表征

2023-03-011
OAAI
Neutralising antibody potency against SARS-CoV-2 wild- type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study
2023-02-0125
OAAI
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2

SARS-CoV-2自扩增RNA疫苗的COVAC1 2a期扩大安全性和免疫原性研究

2023-02-0118
OAAI
The effect of TRV027 on coagulation in COVID-19: A pilot randomized, placebo-controlled trial

TRV027对新型冠状病毒肺炎凝血功能的影响: 一项随机,安慰剂对照试验

2022-12-145
OAAI
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus (HIV)

针对SARS-CoV-2的加强疫苗接种可诱导人类免疫缺陷病毒 (HIV) 患者产生有效的免疫反应

2022-10-0521
OAAI
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
2022-04-0834
OA
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial

抗新型冠状病毒肺炎自我扩增RNA疫苗的安全性和免疫原性: COVAC1,I期剂量范围试验

2022-02-0194
OAAI
Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trial

英国健康志愿者接受新型冠状病毒肺炎疫苗试验筛查的偶然发现

2021-10-201
OAAI
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
2021-08-01185
OAAI